Industrivärden exits Icelandic Ossur with substantial gain

DISCLOSURE NOTICE

Industrivärden has sold its remaining holding of 14,817,286 shares (corresponding to 3.85% of the votes and capital) in the Icelandic medical technology company Ossur hf. The sale entails that Industrivärden has now divested its entire holding of 89,817,286 shares (corresponding to 23.33% of the votes and capital), for SEK 1,008 M. The sale of the entire holding in Ossur gives rise to a capital gain of SEK 398 M for Industrivärden. Commenting on the sale of its holding in Ossur, Industrivärden’s CEO, Anders Nyrén said: ”Industrivärden was the first international investor to recognize the excellent investment potential in Ossur. We have participated in the development of a company that has expanded strongly with good profitability. Our investment, excluding participation in the new issue of SEK 155 M in September and October, grew in value by approximately 90%. After slightly more than three years as an active owner, we have thus made a good deal with a substantial capital gain.” Stockholm, October 28, 2005 AB INDUSTRIVÄRDEN (publ) For further information, please contact: Anders Nyrén, President and CEO, Industrivärden, tel. +46-8-666 64 00

Subscribe

Documents & Links